Drugs News and Research

RSS

Ness Technologies announces implementation of Oracle E-Business Suite at Teva Czech Industries

Ness Technologies, Inc., a global provider of information technology solutions and services, announced today the start of an Oracle E-Business Suite implementation at Teva Czech Industries s.r.o., a provider of pharmaceutical products. The new system will handle financial and logistics issues, replacing a current QAD MFG/Pro system.

26 Apr 2010

Enhancing residence time improves drug effectivity: Study

Studies led by Stony Brook University professor of chemistry Peter J. Tonge indicate that modifications that enhance the time a drug remains bound to its target, or residence time, may lead to better diagnostic and therapeutic agents.

26 Apr 2010

Anacor Pharmaceuticals, MMV partner to discover and develop promising new malaria therapeutics

Anacor Pharmaceuticals today announced that it has entered into a research agreement with not-for-profit Medicines for Malaria Venture (MMV) to explore Anacor's novel boron chemistry platform for developing new therapeutics for the treatment of malaria. Under the agreement, Anacor will be responsible for leading the research effort and MMV will contribute its extensive malaria drug research expertise as well as financial support.

26 Apr 2010

Driving evolution of antibiotic resistance backwards

The use of antibiotics to treat bacterial infections causes a continual and vicious cycle in which antibiotic treatment leads to the emergence and spread of resistant strains, forcing the use of additional drugs leading to further multi-drug resistance.

26 Apr 2010

Delegates of 2010 CADTH Symposium select Sunnybrook poster as Best Overall Poster

A poster from Sunnybrook Health Sciences Centre entitled "Innovative Technology Conserves Resources and Generates Savings: A Case Study from the Sunnybrook Regional Processing Centre" was voted Best Overall Poster by delegates attending the 2010 CADTH Symposium in Halifax, Nova Scotia.

26 Apr 2010

Middle-school children restricted to R-rated movies less likely to start drinking: Study

Middle-school children whose parents restrict access to R-rated movies are substantially less likely to start drinking than their peers who are allowed to see such films, a new study suggests.

26 Apr 2010

Mirina closes Versant led Series A-1 financing

Mirina Corporation, a privately held biotechnology company focused on the generation of novel microRNA (miRNA) therapeutics with improved properties, announced today that it has closed a Series A-1 financing. The round was led by new investor Versant Ventures. Previous investors Alexandria Real Estate Equities, ARCH Venture Partners, OVP Venture Partners and WRF Capital also participated in the round. In conjunction with this financing, Brian Atwood, Managing Director of Versant Ventures, will join the Board of Directors.

26 Apr 2010

New method helps study interactions needed for formation of lipopolysaccharides

Scientists have combined chemistry and biology research techniques to explain how certain bacteria grow structures on their surfaces that allow them to simultaneously cause illness and protect themselves from the body's defenses.

26 Apr 2010

Successful full face transplant in a 22 hour long operation: Barcelona

In a recent development a team of 30 Spanish surgeons have succeeded in a World’s first full face transplant. The patient had accidentally injured a large part of his face with a shotgun five years ago. This had left him disfigured an unable to breathe, swallow or talk properly. He has undergone nine unsuccessful operations before this operation was planned. In this operation he received the whole of his facial skin, muscles, nose, lips, teeth and cheek bones from a donor in a 22 hour operation at the Vall d'Hebron University Hospital on 20th March. He is on his way to recovery now. This is not the first face transplant but the first full face transplant and also the most complex of its kind.

26 Apr 2010

Charles River Laboratories International, WuXi PharmaTech sign definitive agreement to combine

Charles River Laboratories International, Inc., a leading global provider of research models and associated services and of preclinical drug development services, and WuXi PharmaTech, a leading drug research and development outsourcing company with expertise in discovery chemistry and with operations in China and the United States, today announced that they have signed a definitive agreement under which Charles River and WuXi will combine in a cash and stock transaction valued at approximately $1.6 billion.

26 Apr 2010

WCRI study finds cost per claim for prescription drugs to treat injured workers in Maryland higher

The cost per claim for prescription drugs used to treat injured workers in Maryland was slightly higher than in most study states in a new study by the Workers Compensation Research Institute (WCRI).

26 Apr 2010

Targeted therapy based on molecular signatures for treating lung cancer

The first lung cancer clinical trial to guide targeted therapies to patients based on molecular signatures in tumor biopsies is a step toward personalized care and more effective, efficient clinical trials for new drugs, study leaders reported today during the American Association for Cancer Research 101st Annual Meeting 2010.

24 Apr 2010

Recent business progress at Penwest Pharmaceuticals

Penwest Pharmaceuticals Co. today sent a letter to its shareholders to provide an update on the Company's recent progress and on corporate governance developments.

24 Apr 2010

Temperature-sensing ability in proteins remain a mystery

Scientists at The Scripps Research Institute and the Genomics Institute of the Novartis Research Foundation (GNF) have shed new light on the molecular mechanism that enables us to sense temperature, such as the heat from a sizzling stove. In addition to contributing to our knowledge of basic biology, the findings could one day lead to new therapies for conditions such as acute or chronic inflammatory pain.

24 Apr 2010

New study to assess prevalence of addiction to sunbed use among college students

Young people who regularly use sunbeds often display signs of addiction to using them, a US study has found.

24 Apr 2010

Springfield community members support treatment services provided by Gateway Alcohol and Drug Rehab

Members of the Springfield community turned out in force to support the comprehensive treatment services provided to adults and teens by Gateway Foundation's Alcohol and Drug Rehab's Springfield Treatment Center at an April 14 Open House.

24 Apr 2010

New research project to make anti-malarial drugs more affordable in Third World countries

Dr Geoff Brown, from the University of Reading's Department of Chemistry, is beginning a £400,000 project that could prove vital for the developing world in its ongoing fight against malaria. His research aims to make anti-malarial drugs more affordable in Third World countries where more than 1.5 million people die of the disease every year.

24 Apr 2010

Myths and facts about pediatric cancer

"Your child has cancer." They are words every parent can't imagine hearing.

24 Apr 2010

RXi Pharmaceuticals to present data on rxRNA therapeutic platform development at upcoming conferences

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that senior members of its management will be presenting at upcoming conferences and will highlight critical aspects of the development of RXi's next generation rxRNA™ therapeutic platform as well as specific preclinical data generated with this platform.

24 Apr 2010

Senate Budget Committee approves FY 2011 budget resolution with cuts to foreign aid

The Senate Budget Committee has approved a budget resolution that adheres to President Barack Obama's "proposal to freeze non-defense spending, then goes a bit further" with cuts to "the State Department and other international programs," the Washington Post reports (Montgomery, 4/23).

24 Apr 2010

Drugs News and Research

Ness Technologies announces implementation of Oracle E-Business Suite at Teva Czech Industries

Enhancing residence time improves drug effectivity: Study

Anacor Pharmaceuticals, MMV partner to discover and develop promising new malaria therapeutics

Driving evolution of antibiotic resistance backwards

Delegates of 2010 CADTH Symposium select Sunnybrook poster as Best Overall Poster

Middle-school children restricted to R-rated movies less likely to start drinking: Study

Mirina closes Versant led Series A-1 financing

New method helps study interactions needed for formation of lipopolysaccharides

Successful full face transplant in a 22 hour long operation: Barcelona

Charles River Laboratories International, WuXi PharmaTech sign definitive agreement to combine

WCRI study finds cost per claim for prescription drugs to treat injured workers in Maryland higher

Targeted therapy based on molecular signatures for treating lung cancer

Recent business progress at Penwest Pharmaceuticals

Temperature-sensing ability in proteins remain a mystery

New study to assess prevalence of addiction to sunbed use among college students

Springfield community members support treatment services provided by Gateway Alcohol and Drug Rehab

New research project to make anti-malarial drugs more affordable in Third World countries

Myths and facts about pediatric cancer

RXi Pharmaceuticals to present data on rxRNA therapeutic platform development at upcoming conferences

Senate Budget Committee approves FY 2011 budget resolution with cuts to foreign aid

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News